abstract |
The present invention relates to a pharmaceutical composition comprising as active substance, at least one compound comprising, or consisting of, a polypeptide which comprises, or consists of, at least 11 contiguous amino acids selected from X 1 -S-D-I-F-X 2 -G-E-P-X 3 -L-X 4 -P-X 5 -X 6 -X 7 -X 8 -X 9 -Q-L (SEQ ID NO: 13). |